Skip Page Header

Home > Health and social responses to drug problems: a European guide 2021.

European Monitoring Centre for Drugs and Drug Addiction. (2021) Health and social responses to drug problems: a European guide 2021.

External website: https://www.emcdda.europa.eu/publications/health-a...


The Health and social responses to drug problems: a European guide 2021 was developed to support practitioners and policymakers in tackling the negative consequences of drug use. The guide is composed of four sets of miniguides that look at responses to a range of drug problems in Europe. Framing the miniguides are two central resources: an action framework for developing responses and a set of strategies for successful implementation. Several spotlights frame issues cross-cutting the different components.

Action framework for developing and implementing health and social responses to drug problems.
The action framework introduced here will help to clarify current thinking about the response process and the factors to take into account at each stage. This will be of particular interest to those planning health and social policy or interventions to address drug problems, but can equally apply to responses at the individual level.

Patterns of use
Miniguides considering problems from the perspective of particular patterns of drug use and the specific substances that are of concern.

  • Cannabis: health and social responses
    This cannabis miniguide provides an overview of the most important aspects to consider when planning or delivering health and social responses to cannabis-related problems, and reviews the effectiveness of the available responses. It also considers implications for policy and practice.
  • Non-medical use of medicines: health and social responsesThis miniguide on non-medical use of medicines provides an overview of the most important aspects to consider when planning or delivering health and social responses to problems related to the non-medical use of medicines, and reviews the availability and effectiveness of the responses. It also considers implications for policy and practice.
  • Opioids: health and social responses The opioids miniguide provides an overview of the most important aspects to consider when planning or delivering health and social responses to opioid-related problems, and reviews the availability and effectiveness of the responses. It also considers implications for policy and practice.
  • Stimulants: health and social responses The stimulants miniguide provides an overview of what to consider when planning or delivering health and social responses to stimulant-related problems and reviews the available interventions and their effectiveness. It also considers implications for policy and practice.
Item Type
Webpage
Publication Type
Irish-related, International, Guideline, Report, Web Resource
Drug Type
Substances (not alcohol/tobacco), Cannabis, CNS depressants / Sedatives, CNS stimulants, Cocaine, Inhalents and solvents, Opioid, New psychoactive substance, Prescription/Over the counter
Intervention Type
General / Comprehensive, Drug therapy, Treatment method, Prevention, Harm reduction, Psychosocial treatment method, Rehabilitation/Recovery, Screening / Assessment, Policy
Date
October 2021
Publisher
EMCDDA
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote

Repository Staff Only: item control page